Replies to post #114928 on Biotech Values

[acgood]

Exactly...Promacta did about $48m in sales for ITP in 2010 resulting in LGND royalties of ~$2m. Even if Promacta were to become a modestly successful seller, LGND royalties would be substantial for a sub-$200m market cap company. Royalty rate tops out at 9.3% of everything over $400m/year